EcoDrugPlus

Inositol Polyphosphate-5-Phosphatase D

Ensembl ID : ENSPSNG00000004289
Gene Symbol: INPP5D
1 Cross references
213 Possible Orthologues:

Insulin Like Growth Factor 1 Receptor

Ensembl ID : ENSPSNG00000006634
Gene Symbol: IGF1R
3 Cross references
274 Possible Orthologues:

Insulin Receptor

Ensembl ID : ENSPSNG00000007930
Gene Symbol: INSR
3 Cross references
288 Possible Orthologues:

Integrin Subunit Alpha 2b

Ensembl ID : ENSPSNG00000018166
Gene Symbol: ITGA2B
3 Cross references
189 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSPSNG00000005792
Gene Symbol: ITGA4
3 Cross references
236 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSPSNG00000014389
Gene Symbol: ITGA5
3 Cross references
269 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSPSNG00000004427
Gene Symbol: ITGAV
3 Cross references
243 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSPSNG00000009566
Gene Symbol: ITGB1
3 Cross references
299 Possible Orthologues:

Integrin Subunit Beta 3

Ensembl ID : ENSPSNG00000013497
Gene Symbol: ITGB3
3 Cross references
265 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSPSNG00000006664
Gene Symbol: ITGB5
3 Cross references
210 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSPSNG00000003650
Gene Symbol: ITGB6
3 Cross references
206 Possible Orthologues:

Integrin Subunit Beta 7

Ensembl ID : ENSPSNG00000005404
Gene Symbol: ITGB7
3 Cross references
160 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).